Perrigo | PRGO - Pre Tax Profit


Perrigo reported $-1.33B in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
AbbVie USD 5.57B 2.9B Mar/2026
Abbott USD 2.39B 27M Mar/2026
Bayer EUR -3.37B 2.21B Dec/2025
Bristol-Myers Squibb USD 1.47B 1.64B Dec/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Corcept Therapeutics USD 9.91M 5.33M Dec/2025
Dr.Reddys Laboratories INR 4.58B 11.09B Mar/2026
Eli Lilly USD 8.27B 1.03B Dec/2025
J&J USD 8.66B 839M Jun/2026
Merck USD 3.42B 3.32B Dec/2025
Nestle CHF 7.24B 1.1B Jun/2024
Pacira USD 571K 8.95M Dec/2025
Perrigo USD -1.33B 1.35B Dec/2025
Pfizer USD 5.18B 6.82B Mar/2026
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 61.81M 7.32M Dec/2025
Reckitt Benckiser GBP 1.54B 73M Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Supernus Pharmaceuticals USD -5.95M 4.04M Mar/2026
Teva Pharmaceutical Industries USD 753M 662M Mar/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026
Zoetis USD 761M 126M Dec/2025